Astrid B Birkenaes

Summary

Affiliation: University of Oslo
Country: Norway

Publications

  1. ncbi Sociodemographic characteristics and cardiovascular risk factors in patients with severe mental disorders compared with the general population
    Astrid B Birkenaes
    Department of Psychiatry, Ulleval University Hospital and University of Oslo, Norway
    J Clin Psychiatry 67:425-33. 2006
  2. ncbi The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study
    Astrid B Birkenaes
    Division of Psychiatry, Ulleval University Hospital, Oslo, Norway
    J Clin Psychiatry 68:917-23. 2007
  3. ncbi Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions
    Astrid B Birkenaes
    Section for Psychosis Research, Division of Psychiatry, Ulleval University Hospital and Institute of Psychiatry, Oslo, Norway
    J Clin Psychopharmacol 28:132-7. 2008
  4. ncbi Hormonal markers of metabolic dysregulation in patients with severe mental disorders after olanzapine treatment under real-life conditions
    Astrid B Birkenaes
    Department of Psychiatry, Akershus University Hospital, Lørenskog, Norway
    J Clin Psychopharmacol 29:109-16. 2009
  5. ncbi Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunction
    Carmen Simonsen
    Department of Psychiatry, Ulleval University Hospital, and Institute of Psychology, University of Oslo, Oslo, Norway
    Bipolar Disord 10:245-55. 2008
  6. ncbi Delusions are associated with poor cognitive insight in schizophrenia
    John A Engh
    Section of Psychosis Research, Division of Psychiatry, Ulleval University Hospital, Oslo, Norway
    Schizophr Bull 36:830-5. 2010
  7. ncbi Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level
    Halldora Jonsdottir
    Section for Psychosis Research, Department of Psychiatry, Oslo University Hospital Ulleval, Oslo, Norway
    J Clin Psychopharmacol 30:169-75. 2010
  8. ncbi Emotion perception and learning potential: mediators between neurocognition and social problem-solving in schizophrenia?
    Anja Vaskinn
    Institute of Psychiatry, University of Oslo, Oslo, Norway
    J Int Neuropsychol Soc 14:279-88. 2008
  9. ncbi Measuring cognitive insight in schizophrenia and bipolar disorder: a comparative study
    John A Engh
    Division of Psychiatry, Ulleval University Hospital, Oslo, Norway
    BMC Psychiatry 7:71. 2007
  10. ncbi Genome-wide association study identifies genetic loci associated with body mass index and high density lipoprotein-cholesterol levels during psychopharmacological treatment - a cross-sectional naturalistic study
    Lavinia Athanasiu
    Institute of Clinical Medicine, University of Oslo, Oslo, Norway
    Psychiatry Res 197:327-36. 2012

Detail Information

Publications14

  1. ncbi Sociodemographic characteristics and cardiovascular risk factors in patients with severe mental disorders compared with the general population
    Astrid B Birkenaes
    Department of Psychiatry, Ulleval University Hospital and University of Oslo, Norway
    J Clin Psychiatry 67:425-33. 2006
    ....
  2. ncbi The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study
    Astrid B Birkenaes
    Division of Psychiatry, Ulleval University Hospital, Oslo, Norway
    J Clin Psychiatry 68:917-23. 2007
    ..It also compares the prevalence of risk factors in each diagnostic group with the general population...
  3. ncbi Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions
    Astrid B Birkenaes
    Section for Psychosis Research, Division of Psychiatry, Ulleval University Hospital and Institute of Psychiatry, Oslo, Norway
    J Clin Psychopharmacol 28:132-7. 2008
    ..We investigated how cardiometabolic risk factors were related to body mass during treatment with different APs under real-life conditions...
  4. ncbi Hormonal markers of metabolic dysregulation in patients with severe mental disorders after olanzapine treatment under real-life conditions
    Astrid B Birkenaes
    Department of Psychiatry, Akershus University Hospital, Lørenskog, Norway
    J Clin Psychopharmacol 29:109-16. 2009
    ..The present study investigated the levels of several metabolic regulatory hormones in psychiatric outpatients treated with different antipsychotics under real-life conditions...
  5. ncbi Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunction
    Carmen Simonsen
    Department of Psychiatry, Ulleval University Hospital, and Institute of Psychology, University of Oslo, Oslo, Norway
    Bipolar Disord 10:245-55. 2008
    ..The aim of this study was to examine whether patients with bipolar I and bipolar II disorder have different neurocognitive profiles...
  6. ncbi Delusions are associated with poor cognitive insight in schizophrenia
    John A Engh
    Section of Psychosis Research, Division of Psychiatry, Ulleval University Hospital, Oslo, Norway
    Schizophr Bull 36:830-5. 2010
    ..The present findings suggest that delusions are associated with low cognitive insight, whereas solitary hallucinations may be associated with high cognitive insight...
  7. ncbi Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level
    Halldora Jonsdottir
    Section for Psychosis Research, Department of Psychiatry, Oslo University Hospital Ulleval, Oslo, Norway
    J Clin Psychopharmacol 30:169-75. 2010
    ..In this naturalistic sample, outpatients with severe mental disorders showed relatively good adherence to prescribed medication, and self-report questionnaires seem to be a valid method for measuring adherence...
  8. ncbi Emotion perception and learning potential: mediators between neurocognition and social problem-solving in schizophrenia?
    Anja Vaskinn
    Institute of Psychiatry, University of Oslo, Oslo, Norway
    J Int Neuropsychol Soc 14:279-88. 2008
    ....
  9. ncbi Measuring cognitive insight in schizophrenia and bipolar disorder: a comparative study
    John A Engh
    Division of Psychiatry, Ulleval University Hospital, Oslo, Norway
    BMC Psychiatry 7:71. 2007
    ..The relationship between the BCIS as a measure of cognitive insight and established methods for assessment of insight of illness was explored in both diagnostic groups...
  10. ncbi Genome-wide association study identifies genetic loci associated with body mass index and high density lipoprotein-cholesterol levels during psychopharmacological treatment - a cross-sectional naturalistic study
    Lavinia Athanasiu
    Institute of Clinical Medicine, University of Oslo, Oslo, Norway
    Psychiatry Res 197:327-36. 2012
    ..This deserves to be replicated in additional populations to provide more evidence for molecular genetic mechanisms of side effects during psychopharmacological treatment...
  11. ncbi Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group
    Carmen Simonsen
    Department of Psychology, University of Oslo, 0317 Oslo, Norway
    Schizophr Bull 37:73-83. 2011
    ..We asked whether neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends more on history of psychosis than diagnostic category or subtype...
  12. ncbi Can learning potential in schizophrenia be assessed with the standard CVLT-II? An exploratory study
    Anja Vaskinn
    Institute of Psychiatry, University of Oslo, Norway
    Scand J Psychol 49:179-86. 2008
    ..This standard administration approach is a promising, time-saving alternative to the modified tests of learning potential used so far...
  13. ncbi Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor
    Sigrun Hope
    Department of Psychiatry, Østfold Hospital, Eidsberg, Norway
    Bipolar Disord 11:726-34. 2009
    ....
  14. ncbi Increased expression of lipid biosynthesis genes in peripheral blood cells of olanzapine-treated patients
    Audun O Vik-Mo
    Dr Einar Martens Research Group for Biological Psychiatry and Bergen Mental Health Research Center, Department of Clinical Medicine, University of Bergen, Norway
    Int J Neuropsychopharmacol 11:679-84. 2008
    ..Transcriptional activation of lipid biosynthesis genes in peripheral blood cells of olanzapine-treated patients suggests a direct lipogenic action of antipsychotic drugs, which may be related to metabolic adverse effects...